These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
715 related items for PubMed ID: 19344651
1. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat. Sacco G, Mario B, Lopez G, Evangelista S, Manzini S, Maggi CA. Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651 [Abstract] [Full Text] [Related]
2. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril. Westendorp B, Schoemaker RG, van Gilst WH, van Veldhuisen DJ, Buikema H. Eur J Pharmacol; 2005 Dec 19; 527(1-3):141-9. PubMed ID: 16310764 [Abstract] [Full Text] [Related]
3. Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat. Sacco G, Bigioni M, Evangelista S, Goso C, Manzini S, Maggi CA. Eur J Pharmacol; 2001 Feb 23; 414(1):71-8. PubMed ID: 11230997 [Abstract] [Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction. Ahmad M, White R, Tan J, Huang BS, Leenen FH. J Cardiovasc Pharmacol; 2008 Jun 23; 51(6):565-72. PubMed ID: 18496146 [Abstract] [Full Text] [Related]
9. Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action. Ferrari R, Cargnoni A, Curello S, Ceconi C, Boraso A, Visioli O. J Cardiovasc Pharmacol; 1992 Jul 23; 20(5):694-704. PubMed ID: 1280730 [Abstract] [Full Text] [Related]
15. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). Cushman DW, Wang FL, Fung WC, Grover GJ, Harvey CM, Scalese RJ, Mitch SL, DeForrest JM. Br J Clin Pharmacol; 1989 Dec 23; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876 [Abstract] [Full Text] [Related]
16. Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. Kuno A, Yamada T, Masuda K, Ogawa K, Sogawa M, Nakamura S, Nakazawa T, Ohara H, Nomura T, Joh T, Shirai T, Itoh M. Gastroenterology; 2003 Apr 23; 124(4):1010-9. PubMed ID: 12671898 [Abstract] [Full Text] [Related]